These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30977801)

  • 1. Evaluating vaccination policies to accelerate measles elimination in China: a meta-population modelling study.
    Hao L; Glasser JW; Su Q; Ma C; Feng Z; Yin Z; Goodson JL; Wen N; Fan C; Yang H; Rodewald LE; Feng Z; Wang H
    Int J Epidemiol; 2019 Aug; 48(4):1240-1251. PubMed ID: 30977801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the burden of congenital rubella syndrome in China and evaluating mitigation strategies: a metapopulation modelling study.
    Su Q; Feng Z; Hao L; Ma C; Hagan JE; Grant GB; Wen N; Fan C; Yang H; Rodewald LE; Wang H; Glasser JW
    Lancet Infect Dis; 2021 Jul; 21(7):1004-1013. PubMed ID: 33515508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of supplementary immunization activities on measles transmission dynamics and implications for measles elimination goals: A mathematical modelling study.
    Shen M; Sun X; Xiao Y; Liu Y; Wang C; Wang Z; Rong L; Peng Z
    J Theor Biol; 2022 Nov; 551-552():111242. PubMed ID: 35952756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress toward measles elimination in the People's Republic of China, 2000-2009.
    Ma C; An Z; Hao L; Cairns KL; Zhang Y; Ma J; Cao L; Wen N; Xu W; Liang X; Yang W; Luo H
    J Infect Dis; 2011 Jul; 204 Suppl 1():S447-54. PubMed ID: 21666198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interpreting the transmissibility of measles in two different post periods of supplementary immunization activities in Hubei, China.
    Chong KC; Zhang C; Zee BC; Luo T; Wang L; Tam GC; Jia KM; Sun R; Wang MH; Guan X
    Vaccine; 2017 Feb; 35(7):1024-1029. PubMed ID: 28111146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles immunity gaps and the progress towards elimination: a multi-country modelling analysis.
    Trentini F; Poletti P; Merler S; Melegaro A
    Lancet Infect Dis; 2017 Oct; 17(10):1089-1097. PubMed ID: 28807627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Adults for Supplementary Immunization Activities of Measles Control in Central China: A Mathematical Modelling Study.
    Chong KC; Zhang C; Jia KM; Zee BCY; Luo T; Wang L; Tam GCH; Sun R; Wang MH; Guan X
    Sci Rep; 2018 Oct; 8(1):16124. PubMed ID: 30382120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in Measles Seroprevalence in China After the Launch of Two Provincial Supplementary Immunization Activities During 2009 to 2013.
    Chong KC; Rui Y; Mohammad KN; Liu Y; Zhou T; Wang MH; Jia KM; He H
    Pediatr Infect Dis J; 2020 Sep; 39(9):867-871. PubMed ID: 32404783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antecedent causes of a measles resurgence in the Democratic Republic of the Congo.
    Scobie HM; Ilunga BK; Mulumba A; Shidi C; Coulibaly T; Obama R; Tamfum JJ; Simbu EP; Smit SB; Masresha B; Perry RT; Alleman MM; Kretsinger K; Goodson J
    Pan Afr Med J; 2015; 21():30. PubMed ID: 26401224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A population profile of measles susceptibility in Tianjin, China.
    Boulton ML; Wang X; Zhang Y; Montgomery JP; Wagner AL; Carlson BF; Ding Y; Li X; Gillespie B; Su X
    Vaccine; 2016 Jun; 34(27):3037-3043. PubMed ID: 27151881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles vaccination in an increasingly immunized and developed world.
    Hayman DTS
    Hum Vaccin Immunother; 2019; 15(1):28-33. PubMed ID: 30156949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining serological and contact data to derive target immunity levels for achieving and maintaining measles elimination.
    Funk S; Knapp JK; Lebo E; Reef SE; Dabbagh AJ; Kretsinger K; Jit M; Edmunds WJ; Strebel PM
    BMC Med; 2019 Sep; 17(1):180. PubMed ID: 31551070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing age-dependent susceptibility to measles in Japan.
    Kinoshita R; Nishiura H
    Vaccine; 2017 Jun; 35(25):3309-3317. PubMed ID: 28501456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress Toward Measles Elimination - China, January 2013-June 2019.
    Ma C; Rodewald L; Hao L; Su Q; Zhang Y; Wen N; Fan C; Yang H; Luo H; Wang H; Goodson JL; Yin Z; Feng Z
    MMWR Morb Mortal Wkly Rep; 2019 Dec; 68(48):1112-1116. PubMed ID: 31805034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of low measles vaccination coverage in children living in an endemic area.
    Lo Vecchio A; Cambriglia MD; Fedele MC; Basile FW; Chiatto F; Miraglia Del Giudice M; Guarino A
    Eur J Pediatr; 2019 Feb; 178(2):243-251. PubMed ID: 30430239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of measles epidemics in China (1951-2004) and implications for elimination: A case study of three key locations.
    Yang W; Li J; Shaman J
    PLoS Comput Biol; 2019 Feb; 15(2):e1006806. PubMed ID: 30716080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of nationwide supplementary immunization in Lao People's Democratic Republic: Population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and a stability testing of the vaccine.
    Hachiya M; Miyano S; Mori Y; Vynnycky E; Keungsaneth P; Vongphrachanh P; Xeuatvongsa A; Sisouk T; Som-Oulay V; Khamphaphongphane B; Sengkeopaseuth B; Pathammavong C; Phounphenghak K; Kitamura T; Takeda M; Komase K
    PLoS One; 2018; 13(3):e0194931. PubMed ID: 29596472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling the incidence of measles in Canada: an assessment of the options for vaccination policy.
    Gay NJ; Pelletier L; Duclos P
    Vaccine; 1998 May; 16(8):794-801. PubMed ID: 9627936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress toward measles elimination—Philippines, 1998-2014.
    Takashima Y; Schluter WW; Mariano KM; Diorditsa S; de Quiroz Castro M; Ou AC; Ducusin MJ; Garcia LC; Elfa DC; Dabbagh A; Rota P; Goodson JL;
    MMWR Morb Mortal Wkly Rep; 2015 Apr; 64(13):357-62. PubMed ID: 25856257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.